Molecules, Vol. 25, Pages 4340: Urinary Resveratrol Metabolites Output: Differential Associations with Cardiometabolic Markers and Liver Enzymes in House-Dwelling Subjects Featuring Metabolic Syndrome

Molecules, Vol. 25, Pages 4340: Urinary Resveratrol Metabolites Output: Differential Associations with Cardiometabolic Markers and Liver Enzymes in House-Dwelling Subjects Featuring Metabolic Syndrome Molecules doi: 10.3390/molecules25184340 Authors: Vanessa Bullón-Vela Itziar Abete Maria Angeles Zulet Yifan Xu Miguel A. Martínez-González Carmen Sayón-Orea Miguel Ruiz-Canela Estefanía Toledo Vicente Martín Sánchez Ramon Estruch Rosa María Lamuela-Raventós Enrique Almanza-Aguilera Montserrat Fitó Jordi Salas-Salvadó Andrés Díaz-López Francisco J. Tinahones Josep A. Tur Dora Romaguera Jadwiga Konieczna Xavier Pintó Lidia Daimiel Ana Rodriguez-Mateos José Alfredo Martínez Metabolic syndrome (MetS) components are strongly associated with increased risk of non-alcoholic fatty liver disease (NAFLD) development. Several studies have supported that resveratrol is associated with anti-inflammatory and antioxidant effects on health status. The main objective of this study was to assess the putative associations between some urinary resveratrol phase II metabolites, cardiometabolic, and liver markers in individuals diagnosed with MetS. In this cross-sectional study, 266 participants from PREDIMED Plus study (PREvención con DIeta MEDiterránea) were divided into tertiles of total urinary resveratrol phase II metabolites (sum of five resveratrol conjugation metabolites). Urinary resveratrol m...
Source: Molecules - Category: Chemistry Authors: Tags: Article Source Type: research